Dr. Andrew Zelenetz, from Memorial Sloan-Kettering Cancer Center, Discusses the Chemotherapy Delivery Process
Andrew D. Zelenetz, MD, Chief, Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), Associate Professor of Medicine, Weill Cornell Medical College, discusses the chemotherapy delivery process that is in place at MSKCC.
Ideally the treatment that the oncologist prescribes is what the patients should receive. It is, however, a human process that can easily result in errors. The old paper system lends itself to errors and as a result a system needs to exist that verifies and checks each order.
At MSKCC there are several measures in place to catch any errors that may occur. Once the oncologist decides on the treatment it is sent to a chemotherapy nurse who reviews for errors and whether the regimen is known and common for the disease. The orders then pass through a second check with the pharmacist who ensures it is the correct dose and timing. The final stage of the verification process is the treating nurse. When the nurse received the mixed drugs they ensure it matches the order.
The goal of this system is to ensure as little errors as possible. The multiple checks and rechecks help prevent any errors from reaching the patient.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).